Impact of docosahexaenoic acid on gene expression during osteoclastogenesis in vitro-A comprehensive analysis

Nutrients

Volumn 5, Issue 8, 2013, Pages 3151-3162

  Akiyama, Masako ^a   Nakahama, Ken Ichi ^a   Morita, Ikuo ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Docosahexaenoic acid; Osteoclast; Polyunsaturated fatty acid

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OSTEOCLAST DIFFERENTIATION FACTOR;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL COMMUNICATION; CELL FUSION; CELL MOTILITY; CONTROLLED STUDY; DC STAMP GENE; DOWN REGULATION; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE ONTOLOGY ANALYSIS; GENETIC ANALYSIS; IN VITRO STUDY; MALE; MICROARRAY ANALYSIS; MORPHOGENESIS; MOUSE; MST1R GENE; NONHUMAN; OSTEOCLASTOGENESIS; POLYMERASE CHAIN REACTION; SIGLEC 15 GENE; TSPAN7 GENE; UPREGULATION;

EID: 84881576360     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu5083151     Document Type: Article

References (31)

1. Högström, M.; Nordström, P.; Nordström, A. N-3 fatty acids are positively associated with peak bone mineral density and bone accrual in healthy men: The NO2 study. Am. J. Clin. Nutr. 2007, 85, 803-807.
2. Farina, E.K.; Kiel, D.P.; Roubenoff, R.; Schaefer, E.J.; Cupples, L.A.; Tucker, K.L. Plasma phosphatidylcholine concentrations of polyunsaturated fatty acids are differentially associated with hip bone mineral density and hip fracture in older adults: The framingham osteoporosis study. J. Bone Miner. Res. 2012, 27, 1222-1230.
3. Figueredo, C.M.; Martinez, G.L.; Koury, J.C.; Fischer, R.G.; Gustafsson, A. Serum levels of long-chain polyunsaturated fatty acids in patients with periodontal disease. J. Periodontol. 2013, 84, 675-682.
4. Dunstan, J.A.; Mori, T.A.; Barden, A.; Beilin, L.J.; Taylor, A.L.; Holt, P.G.; Prescott, S.L. Fish oil supplementation in pregnancy modifies neonatal alergen-specific immune responses and clinical outcomes in infants at high risk of atopy: A randomized, controlled trial. J. Allergy Clin. Immunol. 2003, 112, 1178-1184
5. Vaughan, V.C.; Hassing, M.-R.; Lewandowski, P.A. Marine polyunsaturated fatty acids and cancer therapy. Br. J. Cancer 2013, 108, 486-492.
6. Kim, Y.-J.; Kim, O.Y.; Cho, Y.; Chung, J.H.; Jung, Y.-S.; Hwang, G.-S.; Shin, M.-J. Plasma phospholipid fatty acid composition in ischemic stroke: Importance of docosahexaenoic acid in the risk for intracranial atherosclerotic stenosis. Atherosclerosis 2012, 225, 418-424.
7. Quinn, J.F.; Raman, R.; Thomas, R.G.; Yurko-Mauro, K.; Nelson, E.B.; Dyck, C.V.; Galvin, J.E.; Emond, J.; Jack, C.R.; Weiner, M.; et al. Docosahexaenoic acid supplementation and cognitive decline in alzheimer disease: A randomized trial. JAMA 2010, 304, 1903-1911.
8. Park, Y.; Lee, A.; Shim, S.C.; Lee, J.H.; Choe, J.Y.; Ahn, H.; Choi, C.B.; Sung, Y.K.; Bae, S.C. Effect of n-3 polyunsaturated fatty acid supplementation in patients with rheumatoid arthritis: A 16-week randomized, double-blind, placebo-controlled, parallel-design multicenter study in Korea. J. Nutr. Biochem. 2013, 24, 1367-1372.
9. Rizos, E.C.; Evangelia, E.; Ntzani, E.E.; Eftychia Bika, E.; Kostapanos, M.S.; Elisaf, M.S. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: A systematic review and meta-analysis. JAMA 2012, 308, 1204-1033.
10. Mori, T.A.; Bao, D.Q.; Burke, V.; Puddey, I.B.; Beilin, L.J. Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Hypertension 1999, 34, 253-260.
11. Rousseau-Ralliard, D.; Moreau, D.; Guilland, J.C.; Raederstorff, D.; Grynberg, A. Docosahexaenoic acid, but not eicosapentaenoic acid, lowers ambulatory blood pressure and shortens interval qt in spontaneously hypertensive rats in vivo. Prostaglandins Leukot. Essent. Fatty Acids 2009, 80, 269-277.
12. Yuan, J.; Akiyama, M.; Nakahama, K.; Sato, T.; Uematsu, H.; Morita, I. The effects of polyunsaturated fatty acids and their metabolites on osteoclastogenesis in vitro. Prostaglandins Other Lipid Mediat. 2010, 92, 85-90.
13. Zhu, M.; Van Dyke, T.E.; Gyurko, R. Resolvin E1 regulates osteoclast fusion via DC-STAMP and NFATc1. FASEB J. 2013, 29, doi:10.1096/fj.12-220228.
14. Wardhana; Surachmanto, E.S.; Datau, E.A. The role of omega-3 fatty acids contained in olive oil on chronic inflammation. Acta Med. Indones. 2011, 43, 138-143.
15. Kobayashi, Y.; Take, I.; Yamashita, T.; Mizoguchi, T.; Ninomiya, T.; Hattori, T.; Kurihara, S.; Ozawa, H.; Udagawa, N.; Takahashi, N. Prostaglandin e2 receptors ep2 and ep4 are down-regulated during differentiation of mouse osteoclasts from their precursors. J. Biol. Chem. 2005, 280, 24035-24042.
16. Jiang, J.; Lv, H.S.; Lin, J.H.; Jiang, D.F.; Chen, Z.K. Ltb4 can directly stimulate human osteoclast formation from pbmc independent of rankl. Artif. Cells Blood Substit. Immobil. Biotechnol. 2005, 33, 391-403.
17. Chen, Z.K.; Lv, H.S.; Jiang, J. Ltb4 can stimulate human osteoclast differentiation dependent of rankl. Artif. Cells Blood Substit. Immobil. Biotechnol. 2010, 38, 52-56.
18. Krönke, G.; Uderhardt, S.; Katzenbeisser, J.; Schett, G. The 12/15-lipoxygenase pathway promotes osteoclast development and differentiation. Autoimmunity 2009, 42, 383-385.
19. Fong, L.; Muhlhausler, B.S.; Gibson, R.A.; Xian, C.J. Perinatal maternal dietary supplementation of.3-fatty acids transiently affects bone marrow microenvironment, osteoblast and osteoclast formation, and bone mass in male offspring. Endocrinology 2012, 153, 2455-2465.
20. Kukita, T.; Wada, N.; Kukita, A.; Kakimoto, T.; Sandra, F.; Toh, K.; Nagata, K.; Iijima, T.; Horiuchi, M.; Matsusaki, H.; et al. Rankl-induced dc-stamp is essential for osteoclastogenesis. J. Exp. Med. 2004, 200, 941-946.
21. Yagi, M.; Ninomiya, K.; Fujita, N.; Suzuki, T.; Iwasaki, R.; Morita, K.; Hosogane, N.; Matsuo, K.; Toyama, Y.; Suda, T.; et al. Induction of dc-stamp by alternative activation and downstream signaling mechanisms. J. Bone Miner. Res. 2007, 22, 992-1001.
22. Courtial, N.; Smink, J.J.; Kuvardina, O.N.; Leutz, A.; Göthert, J.R.; Lausen, J. Tal1 regulates osteoclast differentiation through suppression of the master regulator of cell fusion dc-stamp. FASEB J. 2012, 26, 523-532.
23. Ishida-Kitagawa, N.; Tanaka, K.; Bao, X.; Kimura, T.; Miura, T.; Kitaoka, Y.; Hayashi, K.; Sato, M.; Maruoka, M.; Ogawa, T.; et al. Siglec-15 protein regulates formation of functional osteoclasts in concert with dnax-activating protein of 12 kda (dap12). J. Biol. Chem. 2012, 287, 17493-17502.
24. Asagiri, M.; Sato, K.; Usami, T.; Ochi, S.; Nishina, H.; Yoshida, H.; Morita, I.; Wagner, E.F.; Mak, T.W.; Serfling, E.; et al. Autoamplification of nfatc1 expression determines its essential role in bone homeostasis. J. Exp. Med. 2005, 202, 1261-1269.
25. Iwai, K.; Ishii, M.; Ohshima, S.; Miyatake, K.; Saeki, Y. Expression and function of transmembrane-4 superfamily (tetraspanin) proteins in osteoclasts: Reciprocal roles of tspan-5 and net-6 during osteoclastogenesis. Allergol. Int. 2007, 56, 457-463.
26. Bassani, S.; Cingolani, L.A.; Valnegri, P.; Folci, A.; Zapata, J.; Gianfelice, A.; Sala, C.; Goda, Y.; Passafaro, M. The x-linked intellectual disability protein tspan7 regulates excitatory synapse development and ampar trafficking. Neuron 2012, 73, 1143-1158.
27. Bolia, A.; Gerek, Z.N.; Keskin, O.; Banu Ozkan, S.; Dev, K.K. The binding affinities of proteins interacting with the pdz domain of pick1. Proteins 2012, 80, 1393-1408.
28. Ammendrup-Johnsen, I.; Thorsen, T.S.; Gether, U.; Madsen, K.L. Serine 77 in the pdz domain of pick1 is a protein kinase ca phosphorylation site regulated by lipid membrane binding. Biochemistry 2012, 51, 586-596.
29. Rucci, N.; DiGiacinto, C.; Orrù, L.; Millimaggi, D.; Baron, R.; Teti, A. A novel protein kinase c alpha-dependent signal to erk1/2 activated by alphavbeta3 integrin in osteoclasts and in chinese hamster ovary (cho) cells. J. Cell Sci. 2005, 118, 3263-3275.
30. Sato, K.; Suematsu, A.; Nakashima, T.; Takemoto-Kimura, S.; Aoki, K.; Morishita, Y.; Asahara, H.; Ohya, K.; Yamaguchi, A.; Takai, T.; et al. Regulation of osteoclast differentiation and function by the camk-creb pathway. Nat. Med. 2006, 12, 1410-1416.
31. Kurihara, N.; Tatsumi, J.; Arai, F.; Iwama, A.; Suda, T. Macrophage-stimulating protein (msp) and its receptor, ron, stimulate human osteoclast activity but not proliferation: Effect of msp distinct from that of hepatocyte growth factor. Exp. Hematol. 1998, 26, 1080-1085.